CBIZ CBZ
CBIZ completes acquisition
NYSE delisting decision, Item 1.02 Ends material agreement, Item 2.01 Completes acquisition or sale, Item 3.01 Listing standards notice
- Form
- 8-K
- Filed
- Importance
- Major
- Accession
- 0001193125-26-442819
- $55.00 per share cash for common stock
- Company Options converted to cash based on exercise price
- Unvested Company RSUs (shares paid out over time) converted to Replacement RSU Awards
- Performance Share Units converted to cash based on Merger Consideration
Written from the 8-K on EDGAR. Check the filing before you rely on it.
The reading, claim by claim
- The filing cites Item 1.02 and Item 2.01, which detail the termination of the Amended and Restated Credit Agreement and the conversion of common stock into cash.
- The merger resulted in the cancellation of shares and options, with shareholders receiving $55.00 per share.
- This is covered in Item 3.01, which outlines the steps to remove the company from the NYSE and deregister its shares.
- The delisting follows the merger's closing on November 2, 2026.
4 of 7 claims matched the filing text.
Not found in the filing text
- In its 10-Q for the quarter ended September 30, 2026, CBIZ reported revenue of $702.2 million and net income of $36.8 million.
- The company's gross margin was 16.2%, with operating and net margins of 10.8% and 5.2%, respectively.
- Revenue increased by 1.2% compared to the same period a year earlier.
From the filing
Item 1.02.
Termination of a Material Definitive Agreement1
The information provided in the Introductory Note and Item 2.01 of this Current Report on Form 8-K is incorporated herein by reference into this Item 1.02.
Credit Facility Termination
On November 2, 2026, concurrently with the closing of the Merger, the Company caused the termination and repayment in full of all indebtedness, liabilities and other obligations under the Amended and Restated Credit Agreement, dated as of November 1, 2024, by and among the Company, Bank of America, N.A., as administrative agent, and the other parties thereto (as amended, restated, amended and restated, supplemented, refinanced, replaced or otherwise modified from time to time).
Item 2.01.
Completion of Acquisition or Disposition of Assets1
The information provided in the Introductory Note and in Items 1.02, 3.03, 5.01, 5.02, 5.03 and 8.01 of this Current Report on Form 8-K is incorporated herein by reference into this Item 2.01.
Pursuant to the terms and conditions of the Merger Agreement, the common stock of the Company and each outstanding equity award was treated as follows:
•
Company Common Stock: At the effective time of the Merger (the "Effective Time"), each share of common stock2, par value $0.01 per share, of the Company ("Company Common Stock") issued and outstanding immediately prior to the Effective Time ((a) other than Company Common Stock owned by (i) Parent or Merger Sub or any of their respective subsidiaries, (ii) the Company as treasury stock, (iii) the Company's direct or indirect wholly owned subsidiaries and (iv) stockholders who have perfected and not withdrawn a demand for appraisal rights in accordance with Section 262 of the Delaware General Corporation Law ("DGCL") and (b) including for the avoidance of doubt, Company Common Stock, other than the Performance Shares (as defined in the Marcum Agreement, the "Marcum Performance Shares") issued immediately prior to the Effective Time in accordance with the terms of the Marcum Agreement) was cancelled and automatically converted into the right to receive an amount in cash equal to $55.00 per share2, without interest thereon (the "Merger Consideration").
•
Company Options : Immediately prior to the Effective Time, each option to purchase Company Common Stock (a "Company Option") granted under the 2019 CBIZ, Inc. Omnibus Incentive Plan (the "Company Stock Plan") outstanding immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the applicable exercise price per share of Company Common Stock underlying such Company Option and
Item 3.01.
Item 3.01.
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
The information provided in the Introductory Note and Item 2.01 of this Current Report on Form 8-K is incorporated herein by reference into this Item 3.01.
On November 2, 2026, in connection with the completion of the Merger4, the Company notified the New York Stock Exchange (the "NYSE") of the consummation of the Merger and requested that the NYSE suspend trading of the shares of Company Common Stock prior to the opening of trading on November 2, 2026. The Company also requested that the NYSE file with the SEC a notification of removal from listing and registration on Form 25 to effect the delisting of shares of the Company Common Stock from the NYSE and the deregistration of such shares under Section 12(b) of the Securities Exchange Act of 1934, as amended3 (the "Exchange Act").
Following the effectiveness of the Form 25, the Surviving Corporation intends to file with the SEC a certification on Form 15 requesting the termination of the registration of Company Common Stock under Section 12(g) of the Exchange Act and the suspension of the Company's reporting obligations under Sections 13(a) and 15(d) of the Exchange Act.
Similar companies
Companies of similar size in SIC 7389 and related industry codes: the same peer list as the financial tables.
- Maximus MMS public float $3.8B, Mar 31, 2025, over 18 months old
- ADT ADT public float $4.3B, Jun 30, 2025
- Amentum Holdings AMTM public float $4.4B, Mar 28, 2025, over 18 months old
- Remitly Global RELY public float $3.2B, Jun 30, 2025
- Sezzle SEZL public float $3.2B, Jun 30, 2025